Question Quinolones Based on Updated Warnings

September 2018

Stronger warnings will lead to more concerns about quinolone risks.

Quinolone labels already caution about hypo- and hyperglycemia...and certain CNS effects such as agitation, nervousness, or confusion.

Now FDA will require warnings of hypoglycemic coma...especially in the elderly, renal impairment, or in combo with insulin or a sulfonylurea.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Recalls Navigate the Valsartan Recall
Lice Sort Through Head Lice Treatments
Gout Recommend Allopurinol Over Febuxostat for Most Chronic Gout Patients
Cannabinoids Demystify Cannabidiol Oil
Diabetes Expect to Hear About Renal Protection With Flozins and GLP-1 Agonists
Antibiotics Question Quinolones Based on Updated Warnings
Cardiology Consider Limitations When Estimating CV Risk
Menopause Watch for Imvexxy, a New Low-Dose Vaginal Estrogen
Diabetes & Endocrinology Use a Stepwise Approach for Treating Hirsutism
Substance Use Disorder Think of Lucemyra as Similar to Clonidine for Opioid Withdrawal
Medication Errors Stay Sharp to Prevent Errors With Vaccines
Ophthalmology Don't Rely on Color of Eye Drop Caps